Innovent Biologics, Inc. (1801.HK)

HKSE · Healthcare · Biotechnology
80.10 HKD-6.26%As of 2026-11-22 · HKD
Last session low 79.40 HKDLast session high 84.80 HKD
52-week low 69.55 HKD52-week high 112.70 HKD
Market cap (USD)
$17.82B
Sector
Healthcare
P/E (TTM)
105.4x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in HKD.

IndicatorValueReading
RSI (14)38.8In the neutral range (30 to 70)
MACD (12, 26, 9)-1.57Above its signal line (-1.70); histogram 0.13
Bollinger %B (20, 2)17%Inside the bands (78.13 to 89.69)
SMA 2083.91Price is 4.5% below
SMA 5090.19Price is 11.2% below
SMA 20087.81Price is 8.8% below
ATR (20)4.88% of priceAverage true range per day
52-week position24%In the lower part of the 69.55 to 112.70 range

About Innovent Biologics, Inc.

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, Europe, and internationally.

Latest fiscal yearEnded 2025-12-31: revenue of 13.04B CNY and an operating margin of 16.4%.

More in Biotechnology